Centenial Surgical Suture Limited carries a market capitalization of 294.78M, placing it among publicly traded companies globally. Its enterprise value stands at 388.73M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 294.78M |
| Enterprise Value | 388.73M |
Centenial Surgical Suture Limited currently has 3.65M shares outstanding.
| Shares Outstanding | 3.65M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
The price-to-sales ratio is 0.53, and the price-to-book ratio stands at 5.23.
| PE Ratio | N/A |
| PS Ratio | 0.53 |
| PB Ratio | 5.23 |
| P/TBV Ratio | 0.99 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Centenial Surgical Suture Limited trades at an EV/EBITDA multiple of 35.65 and an EV/FCF ratio of 10.93. The EV/Sales ratio of 0.72 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 35.65 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.72 |
| EV / EBITDA | 35.65 |
| EV / EBIT | 35.65 |
| EV / FCF | 10.93 |
Centenial Surgical Suture Limited maintains a current ratio of 1.90, meaning it holds 1.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 37.51, indicating elevated leverage, while an interest coverage ratio of 0.33 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.90 |
| Quick Ratio | 0.01 |
| Debt / Equity | 37.51 |
| Debt / EBITDA | 9.82 |
| Interest Coverage | 0.33 |
| Return on Equity (ROE) | -12.26 |
| Return on Assets (ROA) | -2.70 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 0.45 |
Over the trailing twelve months, Centenial Surgical Suture Limited has paid 1.34M in income taxes, reflecting an effective tax rate of 25.19.
| Income Tax | 1.34M |
| Effective Tax Rate | 25.19 |
Centenial Surgical Suture Limited's stock has declined approximately -44.95913% over the past 52 weeks. The 50-day moving average sits at 86.81, while the 200-day moving average is 94.39.
| Beta (5Y) | N/A |
| 52-Week Price Change | -44.95913% |
| 50-Day Moving Average | 86.81 |
| 200-Day Moving Average | 94.39 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Centenial Surgical Suture Limited generated 538.40M in revenue and converted that into -22.18M in net income, yielding earnings per share of -5.96. EBITDA reached 10.90M, while operating income came in at 10.90M.
| Revenue | 538.40M |
| Gross Profit | 350.93M |
| Operating Income | 10.90M |
| Pretax Income | -20.83M |
| Net Income | -22.18M |
| EBITDA | 10.90M |
| EBIT | 10.90M |
| Earnings Per Share (EPS) | -5.96 |
Centenial Surgical Suture Limited holds 2.06M in cash and equivalents against 107.09M in total debt, resulting in a net debt position of 105.07M. Total book value stands at 54.24M, with working capital of 284.59M providing operational flexibility.
| Cash & Cash Equivalents | 2.06M |
| Total Debt | 107.09M |
| Net Debt | 105.07M |
| Equity (Book Value) | 54.24M |
| Book Value Per Share | 14.58 |
| Working Capital | 284.59M |
Centenial Surgical Suture Limited operates with a gross margin of 65.18, reflecting its pricing power and cost economics. The operating margin of 2.03 and net profit margin of -4.12 provide insight into operational efficiency.
| Gross Margin | 65.18 |
| Operating Margin | 2.03 |
| Pretax Margin | -3.87 |
| Profit Margin | -4.12 |
| EBITDA Margin | 2.03 |
Centenial Surgical Suture Limited posts an Altman Z-Score of 1.48, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.48 |